K. Gurbanov et al., BOSENTAN IMPROVES RENAL REGIONAL BLOOD-FLOW IN RATS WITH EXPERIMENTALCONGESTIVE-HEART-FAILURE, European journal of pharmacology, 310(2-3), 1996, pp. 193-196
The effects of the mixed endothelin receptor antagonist bosentan on re
nal regional haemodynamics were investigated in rats with aorto-caval
fistula, an experimental model of congestive heart failure. A matched
group of normal rats served as control. Injection of bosentan (10 mg/k
g i.v.) to the rats with decompensated congestive heart failure produc
ed an increase in cortical (+ 20%) and medullary (+ 12%) blood flow, a
nd a decrease in vascular resistance in the cortex (- 30%) and medulla
(- 23%), while reducing mean arterial pressure by approximately 10 mm
Hg. In rats with compensated congestive heart failure and in normal a
nimals, infusion of bosentan did not affect blood pressure and cortica
l perfusion. These findings indicate that 1) endothelin receptor block
ade produces beneficial effects on renal haemodynamics in rats with ex
perimental congestive heart failure and 2) endothelin-1 may be involve
d in the pathogenesis of renal hypoperfusion only in decompensated con
gestive heart failure.